| Market Cap | $37.3M | |
| Enterprise Value | — | |
| Revenue | — | — |
| Gross Profit | — | — |
| EBITDA | -$9.9M | — |
| Net Income | -$9.7M | — |
| Diluted EPS | -$1.09 | — |
| Free Cash Flow | -$7.1M | — |
| Ratio | 2023 | 2024 | 2025 | Trend · 3y | vs own | vs sector |
|---|---|---|---|---|---|---|
| ▾Margins | ||||||
| Operating Margin | −2563.50% | — | — | — | — | — |
| EBITDA Margin | −2282.44% | — | — | — | — | — |
| NOPAT Margin | −2025.17% | — | — | — | — | — |
| Net Margin | −2909.12% | — | — | — | — | — |
| FCF Margin | −2097.34% | — | — | — | — | — |
| OCF Margin | −1685.30% | — | — | — | — | — |
| Capex Intensity | 412.04% | — | — | — | — | — |
| ▸Returns on Capital · 3 ratios | ||||||
| ▸DuPont factors (ROE drivers) · 1 ratios | ||||||
| ▸Earnings quality · 1 ratios | ||||||
| ▸Liquidity & coverage · 2 ratios | ||||||
| ▸Leverage · 2 ratios | ||||||
| ▸Working capital · 1 ratios | ||||||
| ▸Per share · 6 ratios | ||||||
| Line | 2023↗ | 2024↗ | 2025↗ |
|---|---|---|---|
| Revenue | $70,069 | — | — |
| R&D Expense | $527,480 | $1.9M | $3.7M |
| YoY % | +254.3% | +98.4% | |
| SG&A Expense | $1.3M | $4.1M | $6.0M |
| YoY % | +203.5% | +47.9% | |
| Operating Income | -$1.8M | -$5.9M | -$9.7M |
| Other Non-Operating Income | — | -$6,834 | $88,746 |
| Pretax Income | -$2.0M | -$5.9M | -$9.3M |
| Income Tax | $42,267 | — | -$105,205 |
| Net Income | -$2.0M | -$5.9M | -$9.2M |
| EPS (Basic) | -$0.33 | -$0.89 | -$1.09 |
| EPS (Diluted) | -$0.33 | -$0.89 | -$1.09 |
| Weighted Avg Shares (Basic) | 6.3M | 6.6M | 8.4M |
| YoY % | +5.0% | +27.7% | |
| Weighted Avg Shares (Diluted) | 6.3M | 6.6M | 8.4M |
| YoY % | +5.0% | +27.7% |
The sector classification is SIC-derived, not official GICS. Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
